CSL Limited (CSL.AX)

295.78 +1.65 (+0.56%) At close: 04:10PM AEDT

CSL Limited

655 Elizabeth Street
Melbourne, VIC 3000
Australia
61 3 9389 1911
https://www.csl.com.au

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 32,698

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Paul F. McKenzie Ph.D.	MD, CEO & Executive Director	6.44M	N/A	1966
Ms. Joy Carolyn Linton B.Com., BComm, GAICD, Grad Dip AFI	Interim Executive Vice President of CSL Behring	3.03M	N/A	1965
Mr. Andy Schmeltz	Executive Vice President of CSL Behring Business Unit (Leave of Absence)	2.18M	N/A	1971
Mr. John A. G. Levy CPA	Interim Chief Financial Officer	N/A	N/A	N/A
Chris Cooper	Head of Investor Relations	N/A	N/A	N/A
Mr. Gregory Boss B.S., BS(Hons), J.D.	Executive VP of Legal & General Counsel	1.61M	N/A	1961
Ms. Roanne Parry	Chief Human Resources Officer	N/A	N/A	1973
Dr. Karen Etchberger	Executive Vice President of Quality & Business Services	1.52M	N/A	1958
Ms. Jemimah Brennan	Head of Communications - Asia Pacific	N/A	N/A	N/A
Dr. Andrew D. Nash BSc (Hons), GAICD, Ph.D.	Senior Vice President of Research	N/A	N/A	1962

Amounts are as of 31 December 2024, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.

Corporate governance

CSL Limited’s ISS governance QualityScore as of 1 October 2024 is 3. The pillar scores are Audit: 4; Board: 4; Shareholder rights: 5; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.